Edition:
United States

Merlin Diamonds Ltd (MED.AX)

MED.AX on Australia Stock Exchange

0.01AUD
27 Jul 2016
Change (% chg)

-- (--)
Prev Close
$0.01
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
157,819
52-wk High
$0.07
52-wk Low
$0.01

MED.AX

Chart for MED.AX

About

Merlin Diamonds Limited is a diamond exploration company. The Company is principally engaged in diamond exploration and development in the Northern Territory of Australia. The Company holds interests in the Merlin Diamond Mine located near Borroloola, Northern Territory, Australia. There are approximately 13 known diamond-bearin... (more)
No analyst recommendations are available for MED.AX.

Overall

Beta: 0.34
Market Cap(Mil.): $6.77
Shares Outstanding(Mil.): 451.26
Dividend: --
Yield (%): --

Financials

  MED.AX Industry Sector
P/E (TTM): -- 1.18 15.54
EPS (TTM): -0.02 -- --
ROI: -58.99 -7.89 7.81
ROE: -65.95 -12.00 8.56

UPDATE 1-UK's Merlin sees boost from weaker pound

* Interim dividend raised 4.8 percent to 2.2 pence (Adds detail, CEO comments)

Jul 28 2016

European shares propped up by firmer bank stocks

LONDON, June 22 European shares gained ground on Wednesday, with two key regional indexes touching their highest level in more than two weeks, as firmer financial stocks propped up markets.

Jun 22 2016

Merlin and Metrovacesa agree merger to form Spain's largest property group

MADRID, June 21 Property companies Merlin and Metrovacesa have signed an agreement to form Spain's largest real estate group by rental assets, according to a company filing with the stock market regulator.

Jun 21 2016

BRIEF-Spain's Merlin signs deal with Metrovacesa to form property group

* Says has signed deal with real estate company Metrovacesa and its largest shareholders to form property group

Jun 21 2016

Merlin Entertainments profit hurt by Alton Towers crash

LONDON, Feb 25 Merlin Entertainments reported flat profit for 2015, held back by a drop in visitors to its Alton Towers theme park in Britain after a rollercoaster crash in June left four people seriously injured.

Feb 25 2016

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Wright Reports
$75.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Sadif Analytics Prime
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.